{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:34:09Z","timestamp":1792467249535,"version":"4.5.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T00:00:00Z","timestamp":1504828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T00:00:00Z","timestamp":1504828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/nrendo.2017.104","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T09:38:33Z","timestamp":1504863513000},"page":"115-125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":517,"title":["Primary hyperparathyroidism"],"prefix":"10.1038","volume":"14","author":[{"given":"Marcella D.","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shonni J.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,8]]},"reference":[{"key":"BFnrendo2017104_CR1","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1056\/NEJM196605262742105","volume":"274","author":"O Cope","year":"1966","unstructured":"Cope, O. The study of hyperparathyroidism at the Massachusetts General Hospital. N. Engl. J. Med. 274, 1174\u20131182 (1966).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2017104_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jc.2012-4022","volume":"98","author":"MW Yeh","year":"2013","unstructured":"Yeh, M. W.  et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J. Clin. Endocrinol. Metab. 98, 1122\u20131129 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1359\/JBMR.050910","volume":"21","author":"RA Wermers","year":"2006","unstructured":"Wermers, R. A.  et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993\u20132001: an update on the changing epidemiology of the disease. J. Bone Miner. Res. 21, 171\u2013177 (2006).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo2017104_CR4","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.surg.2013.06.051","volume":"154","author":"DM Press","year":"2013","unstructured":"Press, D. M.  et al. The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery 154, 1232\u20131237 (2013).","journal-title":"Surgery"},{"key":"BFnrendo2017104_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1056\/NEJM198001243020402","volume":"302","author":"H Heath 3rd","year":"1980","unstructured":"Heath, H. 3rd, Hodgson, S. F. & Kennedy, M. A. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N. Engl. J. Med. 302, 189\u2013193 (1980).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2017104_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.7326\/0003-4819-126-6-199703150-00003","volume":"126","author":"RA Wermers","year":"1997","unstructured":"Wermers, R. A.  et al. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965\u20131992. Ann. Intern. Med. 126, 433\u2013440 (1997).","journal-title":"Ann. Intern. Med."},{"key":"BFnrendo2017104_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2014.12.003","volume":"73","author":"ML Griebeler","year":"2015","unstructured":"Griebeler, M. L.  et al. Secular trends in the incidence of primary hyperparathyroidism over five decades. Bone 73, 1\u20137 (2015).","journal-title":"Bone"},{"key":"BFnrendo2017104_CR8","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","volume":"341","author":"SJ Silverberg","year":"1999","unstructured":"Silverberg, S. J., Shane, E., Jacobs, T. P., Siris, E. & Bilezikian, J. P. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N. Engl. J. Med. 341, 1249\u20131255 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2017104_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/archinte.1980.00330140063019","volume":"140","author":"SD Rao","year":"1980","unstructured":"Rao, S. D.  et al. Hyperparathyroidism following head and neck irradiation. Arch. Intern. Med. 140, 205\u2013207 (1980).","journal-title":"Arch. Intern. Med."},{"key":"BFnrendo2017104_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1046\/j.1365-2796.1996.28864000.x","volume":"240","author":"H Bendz","year":"1996","unstructured":"Bendz, H., Sjodin, I., Toss, G. & Berglund, K. Hyperparathyroidism and long-term lithium therapy \u2014 a cross-sectional study and the effect of lithium withdrawal. J. Intern. Med. 240, 357\u2013365 (1996).","journal-title":"J. Intern. Med."},{"key":"BFnrendo2017104_CR11","doi-asserted-by":"publisher","first-page":"E1995","DOI":"10.1210\/jc.2012-2303","volume":"97","author":"PJ Newey","year":"2012","unstructured":"Newey, P. J.  et al. Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas. J. Clin. Endocrinol. Metab. 97, E1995\u2013E2005 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mce.2013.09.005","volume":"386","author":"J Costa-Guda","year":"2014","unstructured":"Costa-Guda, J. & Arnold, A. Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors. Mol. Cell. Endocrinol. 386, 46\u201354 (2014).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFnrendo2017104_CR13","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1210\/jc.2012-4029","volume":"98","author":"E Pardi","year":"2013","unstructured":"Pardi, E.  et al. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas. J. Clin. Endocrinol. Metab. 98, 2800\u20132810 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/B978-0-12-397166-1.00018-7","volume-title":"The Parathyroids: Basic and Clinical Concepts","author":"AM Arnold","year":"2015","unstructured":"Arnold, A. M. & Levine, M. A. in The Parathyroids: Basic and Clinical Concepts (ed. Bilezikian, J. P.) 279\u2013297 (Academic Press, 2015)."},{"issue":"Suppl. 2","key":"BFnrendo2017104_CR15","first-page":"N37","volume":"17","author":"SJ Marx","year":"2002","unstructured":"Marx, S. J.  et al. Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J. Bone Miner. Res. 17 (Suppl. 2), N37\u2013N43 (2002).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo2017104_CR16","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/joim.12523","volume":"280","author":"RV Thakker","year":"2016","unstructured":"Thakker, R. V. Genetics of parathyroid tumours. J. Intern. Med. 280, 574\u2013583 (2016).","journal-title":"J. Intern. Med."},{"key":"BFnrendo2017104_CR17","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","volume":"99","author":"B Guan","year":"2016","unstructured":"Guan, B.  et al. GCM2-activating mutations in familial isolated hyperparathyroidism. Am. J. Hum. Genet. 99, 1034\u20131044 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrendo2017104_CR18","doi-asserted-by":"publisher","first-page":"E360","DOI":"10.1210\/jc.2014-3238","volume":"100","author":"W Yu","year":"2015","unstructured":"Yu, W.  et al. Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion. J. Clin. Endocrinol. Metab. 100, E360\u2013E364 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1677\/ERC-09-0134","volume":"17","author":"S Corbetta","year":"2010","unstructured":"Corbetta, S.  et al. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Endocr. Relat. Cancer 17, 135\u2013146 (2010).","journal-title":"Endocr. Relat. Cancer"},{"key":"BFnrendo2017104_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.beem.2013.02.006","volume":"27","author":"EM Brown","year":"2013","unstructured":"Brown, E. M. Role of the calcium-sensing receptor in extracellular calcium homeostasis. Best Pract. Res. Clin. Endocrinol. Metab. 27, 333\u2013343 (2013).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR21","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4158\/EP.12.3.302","volume":"12","author":"EJ Mahoney","year":"2006","unstructured":"Mahoney, E. J., Monchik, J. M., Donatini, G. & De Lellis, R. Life-threatening hypercalcemia from a hepatocellular carcinoma secreting intact parathyroid hormone: localization by sestamibi single-photon emission computed tomographic imaging. Endocr. Pract. 12, 302\u2013306 (2006).","journal-title":"Endocr. Pract."},{"key":"BFnrendo2017104_CR22","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1056\/NEJM199011083231907","volume":"323","author":"SR Nussbaum","year":"1990","unstructured":"Nussbaum, S. R., Gaz, R. D. & Arnold, A. Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone. N. Engl. J. Med. 323, 1324\u20131328 (1990).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2017104_CR23","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1373\/clinchem.2003.021592","volume":"49","author":"P D'Amour","year":"2003","unstructured":"D'Amour, P.  et al. Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1\u201384) is overproduced in primary and secondary hyperparathyroidism. Clin. Chem. 49, 2037\u20132044 (2003).","journal-title":"Clin. Chem."},{"key":"BFnrendo2017104_CR24","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1210\/jc.2014-1414","volume":"99","author":"R Eastell","year":"2014","unstructured":"Eastell, R.  et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99, 3570\u20133579 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR25","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm, S. M.  et al. The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 151, 959\u2013968 (2016).","journal-title":"JAMA Surg."},{"key":"BFnrendo2017104_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1210\/jc.2008-1758","volume":"94","author":"R Eastell","year":"2009","unstructured":"Eastell, R.  et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J. Clin. Endocrinol. Metab. 94, 340\u2013350 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR27","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","volume":"368","author":"MA Nesbit","year":"2013","unstructured":"Nesbit, M. A.  et al. Mutations affecting G-protein subunit \u03b111 in hypercalcemia and hypocalcemia. N. Engl. J. Med. 368, 2476\u20132486 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2017104_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/ng.2492","volume":"45","author":"MA Nesbit","year":"2013","unstructured":"Nesbit, M. A.  et al. Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3. Nat. Genet. 45, 93\u201397 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrendo2017104_CR29","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1210\/jc.2006-2802","volume":"92","author":"H Lowe","year":"2007","unstructured":"Lowe, H., McMahon, D. J., Rubin, M. R., Bilezikian, J. P. & Silverberg, S. J. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J. Clin. Endocrinol. Metab. 92, 3001\u20133005 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR30","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1001\/jama.1934.02750160010003","volume":"102","author":"F Albright","year":"1934","unstructured":"Albright, F., Aub, J. & Bauer, W. Hyperparathyroidism: common and polymorphic condition as illustrated by seventeen proven cases in one clinic. JAMA 102, 1276 (1934).","journal-title":"JAMA"},{"key":"BFnrendo2017104_CR31","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1210\/jc.2014-1415","volume":"99","author":"SJ Silverberg","year":"2014","unstructured":"Silverberg, S. J.  et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99, 3580\u20133594 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR32","doi-asserted-by":"publisher","first-page":"648","DOI":"10.9738\/INTSURG-D-14-00094.1","volume":"100","author":"A Usta","year":"2015","unstructured":"Usta, A., Alhan, E., Cinel, A., Turkyilmaz, S. & Erem, C. A 20-year study on 190 patients with primary hyperparathyroidism in a developing country: Turkey experience. Int. Surg. 100, 648\u2013655 (2015).","journal-title":"Int. Surg."},{"key":"BFnrendo2017104_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00005792-197403000-00002","volume":"53","author":"LE Mallette","year":"1974","unstructured":"Mallette, L. E., Bilezikian, J. P., Heath, D. A. & Aurbach, G. D. Primary hyperparathyroidism: clinical and biochemical features. Med. (Baltimore) 53, 127\u2013146 (1974).","journal-title":"Med. (Baltimore)"},{"key":"BFnrendo2017104_CR34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4248\/BR201302005","volume":"1","author":"JM Liu","year":"2013","unstructured":"Liu, J. M.  et al. Primary hyperparathyroidism: a tale of two cities revisited \u2014 New York and Shanghai. Bone Res. 1, 162\u2013169 (2013).","journal-title":"Bone Res."},{"key":"BFnrendo2017104_CR35","first-page":"394","volume":"62","author":"UH Malabu","year":"2007","unstructured":"Malabu, U. H. & Founda, M. A. Primary hyperparathyroidism in Saudi Arabia: a review of 46 cases. Med. J. Malaysia 62, 394\u2013397 (2007).","journal-title":"Med. J. Malaysia"},{"key":"BFnrendo2017104_CR36","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/postgradmedj-2012-131707","volume":"89","author":"IM Paruk","year":"2013","unstructured":"Paruk, I. M., Esterhuizen, T. M., Maharaj, S., Pirie, F. J. & Motala, A. A. Characteristics, management and outcome of primary hyperparathyroidism in South Africa: a single-centre experience. Postgrad. Med. J. 89, 626\u2013631 (2013).","journal-title":"Postgrad. Med. J."},{"key":"BFnrendo2017104_CR37","first-page":"694","volume":"139","author":"VN Shah","year":"2014","unstructured":"Shah, V. N., Bhadada, S., Bhansali, A., Behera, A. & Mittal, B. R. Changes in clinical and biochemical presentations of primary hyperparathyroidism in India over a period of 20 years. Indian J. Med. Res. 139, 694\u2013699 (2014).","journal-title":"Indian J. Med. Res."},{"key":"BFnrendo2017104_CR38","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1210\/jc.2012-2914","volume":"98","author":"L Zhao","year":"2013","unstructured":"Zhao, L.  et al. The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center. J. Clin. Endocrinol. Metab. 98, 721\u2013728 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11926-015-0523-2","volume":"17","author":"F Bandeira","year":"2015","unstructured":"Bandeira, F. & Cassibba, S. Hyperparathyroidism and bone health. Curr. Rheumatol. Rep. 17, 48 (2015).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrendo2017104_CR40","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1590\/S0100-879X2007000400010","volume":"40","author":"UE Oliveira","year":"2007","unstructured":"Oliveira, U. E.  et al. Analysis of the diagnostic presentation profile, parathyroidectomy indication and bone mineral density follow-up of Brazilian patients with primary hyperparathyroidism. Braz. J. Med. Biol. Res. 40, 519\u2013526 (2007).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"BFnrendo2017104_CR41","first-page":"408","volume":"70","author":"FR Spivacow","year":"2010","unstructured":"Spivacow, F. R., Martinez, C. & Polonsky, A. [Primary hyperparathyroidism: postoperative long-term evolution]. Medicina (B. Aires) 70, 408\u2013414 (in Spanish) (2010).","journal-title":"Medicina (B. Aires)"},{"key":"BFnrendo2017104_CR42","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1007\/s00198-015-3199-6","volume":"26","author":"MD Walker","year":"2015","unstructured":"Walker, M. D.  et al. Low vitamin D levels have become less common in primary hyperparathyroidism. Osteoporos. Int. 26, 2837\u20132843 (2015).","journal-title":"Osteoporos. Int."},{"key":"BFnrendo2017104_CR43","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1365-2265.2005.02371.x","volume":"63","author":"B Moosgaard","year":"2005","unstructured":"Moosgaard, B.  et al. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin. Endocrinol. (Oxf.) 63, 506\u2013513 (2005).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2017104_CR44","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/BF03344140","volume":"29","author":"P Boudou","year":"2006","unstructured":"Boudou, P., Ibrahim, F., Cormier, C., Sarfati, E. & Souberbielle, J. C. A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism. J. Endocrinol. Invest. 29, 511\u2013515 (2006).","journal-title":"J. Endocrinol. Invest."},{"key":"BFnrendo2017104_CR45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2265.1992.tb02278.x","volume":"37","author":"MR Clements","year":"1992","unstructured":"Clements, M. R.  et al. The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency. Clin. Endocrinol. (Oxf.) 37, 17\u201327 (1992).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2017104_CR46","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1042\/cs0730659","volume":"73","author":"MR Clements","year":"1987","unstructured":"Clements, M. R.  et al. Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin. Sci. (Lond.) 73, 659\u2013664 (1987).","journal-title":"Clin. Sci. (Lond.)"},{"key":"BFnrendo2017104_CR47","first-page":"1054","volume":"85","author":"DS Rao","year":"2000","unstructured":"Rao, D. S.  et al. Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J. Clin. Endocrinol. Metab. 85, 1054\u20131058 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR48","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0002-9343(99)00294-6","volume":"107","author":"SJ Silverberg","year":"1999","unstructured":"Silverberg, S. J., Shane, E., Dempster, D. W. & Bilezikian, J. P. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am. J. Med. 107, 561\u2013567 (1999).","journal-title":"Am. J. Med."},{"key":"BFnrendo2017104_CR49","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/cen.12210","volume":"79","author":"F Tassone","year":"2013","unstructured":"Tassone, F.  et al. Vitamin D status in primary hyperparathyroidism: a Southern European perspective. Clin. Endocrinol. (Oxf.) 79, 784\u2013790 (2013).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2017104_CR50","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s12020-016-0931-8","volume":"55","author":"G Viccica","year":"2017","unstructured":"Viccica, G., Cetani, F., Vignali, E., Miccoli, M. & Marcocci, C. Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism. Endocrine 55, 256\u2013265 (2017).","journal-title":"Endocrine"},{"key":"BFnrendo2017104_CR51","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1210\/jc.2015-2022","volume":"100","author":"MD Walker","year":"2015","unstructured":"Walker, M. D.  et al. Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation. J. Clin. Endocrinol. Metab. 100, 3443\u20133451 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR52","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s00268-002-6622-z","volume":"26","author":"H Yamashita","year":"2002","unstructured":"Yamashita, H.  et al. Vitamin D status in Japanese patients with hyperparathyroidism: seasonal changes and effect on clinical presentation. World J. Surg. 26, 937\u2013941 (2002).","journal-title":"World J. Surg."},{"key":"BFnrendo2017104_CR53","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00268-005-0239-y","volume":"30","author":"N Ozbey","year":"2006","unstructured":"Ozbey, N.  et al. Correlations between vitamin D status and biochemical\/clinical and pathological parameters in primary hyperparathyroidism. World J. Surg. 30, 321\u2013326 (2006).","journal-title":"World J. Surg."},{"key":"BFnrendo2017104_CR54","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/cen.12062","volume":"78","author":"CN Jayasena","year":"2013","unstructured":"Jayasena, C. N.  et al. Associations of serum 25-hydroxyvitamin D with circulating PTH, phosphate and calcium in patients with primary hyperparathyroidism. Clin. Endocrinol. (Oxf.) 78, 838\u2013843 (2013).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2017104_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1507\/endocrj.K07-102","volume":"55","author":"Y Inoue","year":"2008","unstructured":"Inoue, Y.  et al. Vitamin D status affects osteopenia in postmenopausal patients with primary hyperparathyroidism. Endocr. J. 55, 57\u201365 (2008).","journal-title":"Endocr. J."},{"key":"BFnrendo2017104_CR56","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1530\/eje.1.02197","volume":"155","author":"B Moosgaard","year":"2006","unstructured":"Moosgaard, B.  et al. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study. Eur. J. Endocrinol. 155, 237\u2013244 (2006).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2017104_CR57","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1365-2265.2007.03109.x","volume":"68","author":"B Moosgaard","year":"2008","unstructured":"Moosgaard, B.  et al. Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin. Endocrinol. (Oxf.) 68, 707\u2013715 (2008).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2017104_CR58","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/cen.12398","volume":"80","author":"VN Shah","year":"2014","unstructured":"Shah, V. N., Shah, C. S., Bhadada, S. K. & Rao, D. S. Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature. Clin. Endocrinol. (Oxf.) 80, 797\u2013803 (2014).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2017104_CR59","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1210\/jc.2013-3978","volume":"99","author":"L Rolighed","year":"2014","unstructured":"Rolighed, L.  et al. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J. Clin. Endocrinol. Metab. 99, 1072\u20131080 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR60","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jbmr.5650040302","volume":"4","author":"SJ Silverberg","year":"1989","unstructured":"Silverberg, S. J.  et al. Skeletal disease in primary hyper- parathyroidism. J. Bone Miner. Res. 4, 283\u2013291 (1989).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo2017104_CR61","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1210\/jcem-70-4-930","volume":"70","author":"M Parisien","year":"1990","unstructured":"Parisien, M.  et al. The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J. Clin. Endocrinol. Metab. 70, 930\u2013938 (1990).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR62","doi-asserted-by":"publisher","first-page":"13091315","DOI":"10.1210\/jc.2014-3708","volume":"100","author":"C Cipriani","year":"2015","unstructured":"Cipriani, C.  et al. Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. J. Clin. Endocrinol. Metab. 100, 13091315 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR63","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","volume":"14","author":"S Khosla","year":"1999","unstructured":"Khosla, S.  et al. Primary hyperparathyroidism and the risk of fracture: a population-based study. J. Bone Miner. Res. 14, 1700\u20131707 (1999).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo2017104_CR64","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1210\/jc.2008-2006","volume":"94","author":"E Vignali","year":"2009","unstructured":"Vignali, E.  et al. Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 94, 2306\u20132312 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2265.2007.03162.x","volume":"69","author":"L Mosekilde","year":"2008","unstructured":"Mosekilde, L. Primary hyperparathyroidism and the skeleton. Clin. Endocrinol. (Oxf.) 69, 1\u201319 (2008).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2017104_CR66","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1530\/eje.1.02225","volume":"155","author":"S De Geronimo","year":"2006","unstructured":"De Geronimo, S., Romagnoli, E., Diacinti, D., D'Erasmo, E. & Minisola, S. The risk of fractures in postmenopausal women with primary hyperparathyroidism. Eur. J. Endocrinol. 155, 415\u2013420 (2006).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2017104_CR67","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/jbmr.1841","volume":"28","author":"EM Stein","year":"2013","unstructured":"Stein, E. M.  et al. Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women. J. Bone Miner. Res. 28, 1029\u20131040 (2013).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo2017104_CR68","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1007\/s00198-016-3637-0","volume":"27","author":"MD Walker","year":"2016","unstructured":"Walker, M. D.  et al. Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism. Osteoporos. Int. 27, 3063\u20133071 (2016).","journal-title":"Osteoporos. Int."},{"key":"BFnrendo2017104_CR69","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/jbmr.1540","volume":"27","author":"S Hansen","year":"2012","unstructured":"Hansen, S., Hauge, E. M., Rasmussen, L., Jensen, J. E. & Brixen, K. Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism. A 1-year prospective controlled study using high resolution peripheral quantitative computed tomography. J. Bone Miner. Res. 27, 1150\u20131158 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo2017104_CR70","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s00268-002-6433-2","volume":"26","author":"E Nordenstrom","year":"2002","unstructured":"Nordenstrom, E., Westerdahl, J., Lindergard, B., Lindblom, P. & Bergenfelz, A. Multifactorial risk profile for bone fractures in primary hyperparathyroidism. World J. Surg. 26, 1463\u20131467 (2002).","journal-title":"World J. Surg."},{"key":"BFnrendo2017104_CR71","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian, J. P.  et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99, 3561\u20133569 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR72","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1210\/jc.2014-3441","volume":"100","author":"K Lundstam","year":"2015","unstructured":"Lundstam, K.  et al. Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 100, 1359\u20131367 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR73","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1210\/jc.2011-0569","volume":"96","author":"L Rejnmark","year":"2011","unstructured":"Rejnmark, L., Vestergaard, P. & Mosekilde, L. Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 96, 2377\u20132385 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR74","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.4158\/EP14074.OR","volume":"20","author":"S Cassibba","year":"2014","unstructured":"Cassibba, S.  et al. Silent renal stones in primary hyperparathyroidism: prevalence and clinical features. Endocr. Pract. 20, 1137\u20131142 (2014).","journal-title":"Endocr. Pract."},{"key":"BFnrendo2017104_CR75","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00240-007-0096-2","volume":"35","author":"CV Odvina","year":"2007","unstructured":"Odvina, C. V.  et al. Biochemical characterization of primary hyperparathyroidism with and without kidney stones. Urol. Res. 35, 123\u2013128 (2007).","journal-title":"Urol. Res."},{"key":"BFnrendo2017104_CR76","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1016\/j.juro.2009.01.028","volume":"181","author":"AD Berger","year":"2009","unstructured":"Berger, A. D.  et al. Patients with primary hyperparathyroidism \u2014 why do some form stones? J. Urol. 181, 2141\u20132145 (2009).","journal-title":"J. Urol."},{"key":"BFnrendo2017104_CR77","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1210\/jc.2009-0587","volume":"94","author":"F Tassone","year":"2009","unstructured":"Tassone, F., Gianotti, L., Emmolo, I., Ghio, M. & Borretta, G. Glomerular filtration rate and parathyroid hormone secretion in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 94, 4458\u20134461 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR78","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1210\/jc.2013-4192","volume":"99","author":"MD Walker","year":"2014","unstructured":"Walker, M. D.  et al. Predictors of renal function in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 99, 1885\u20131892 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR79","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1210\/jc.2011-3072","volume":"97","author":"MD Walker","year":"2012","unstructured":"Walker, M. D.  et al. Effect of renal function on skeletal health in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 97, 1501\u20131507 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR80","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1210\/jcem-67-6-1294","volume":"67","author":"DS Rao","year":"1988","unstructured":"Rao, D. S., Wilson, R. J., Kleerekoper, M. & Parfitt, A. M. Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J. Clin. Endocrinol. Metab. 67, 1294\u20131298 (1988).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR81","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1365-2796.1990.tb00166.x","volume":"227","author":"A Kristoffersson","year":"1990","unstructured":"Kristoffersson, A., Backman, C., Granqvist, K. & Jarhult, J. Pre- and postoperative evaluation of renal function with five different tests in patients with primary hyperparathyroidism. J. Intern. Med. 227, 317\u2013324 (1990).","journal-title":"J. Intern. Med."},{"key":"BFnrendo2017104_CR82","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1210\/jc.2007-0219","volume":"92","author":"E Ambrogini","year":"2007","unstructured":"Ambrogini, E.  et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J. Clin. Endocrinol. Metab. 92, 3114\u20133121 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR83","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1210\/jc.2006-1836","volume":"92","author":"J Bollerslev","year":"2007","unstructured":"Bollerslev, J.  et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J. Clin. Endocrinol. Metab. 92, 1687\u20131692 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR84","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1210\/endo.136.7.7789328","volume":"136","author":"K Ogino","year":"1995","unstructured":"Ogino, K., Burkhoff, D. & Bilezikian, J. P. The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology 136, 3024\u20133030 (1995).","journal-title":"Endocrinology"},{"key":"BFnrendo2017104_CR85","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1016\/S0021-9258(18)84940-7","volume":"64","author":"JB Collip","year":"1925","unstructured":"Collip, J. B. & Clark, E. P. Further studies on the physiological action of a parathyroid hormone. J. Biol. Chem. 64, 4485\u2013507 (1925).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2017104_CR86","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.1210\/jc.2009-1086","volume":"94","author":"MD Walker","year":"2009","unstructured":"Walker, M. D.  et al. Carotid vascular abnormalities in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 94, 3849\u20133856 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR87","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1210\/jc.2007-0551","volume":"92","author":"MD Walker","year":"2007","unstructured":"Walker, M. D. & Silverberg, S. J. Parathyroidectomy in asymptomatic primary hyperparathyroidism: improves \u201cbones\u201d but not \u201cpsychic moans\u201d. J. Clin. Endocrinol. Metab. 92, 1613\u20131615 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR88","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1067\/msy.2000.110844","volume":"128","author":"GB Talpos","year":"2000","unstructured":"Talpos, G. B.  et al. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery 128, 1013\u20131020 (2000).","journal-title":"Surgery"},{"key":"BFnrendo2017104_CR89","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.surg.2009.09.034","volume":"146","author":"ND Perrier","year":"2009","unstructured":"Perrier, N. D.  et al. Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with \u201casymptomatic\u201d primary hyperparathyroidism. Surgery 146, 1116\u20131122 (2009).","journal-title":"Surgery"},{"key":"BFnrendo2017104_CR90","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/BF03346443","volume":"31","author":"MD Walker","year":"2008","unstructured":"Walker, M. D. & Silverberg, S. J. Cardiovascular aspects of primary hyperparathyroidism. J. Endocrinol. Invest. 31, 925\u2013931 (2008).","journal-title":"J. Endocrinol. Invest."},{"key":"BFnrendo2017104_CR91","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S0039-6060(97)90216-6","volume":"122","author":"JA Soreide","year":"1997","unstructured":"Soreide, J. A.  et al. Survival after surgical treatment for primary hyperparathyroidism. Surgery 122, 1117\u20131123 (1997).","journal-title":"Surgery"},{"key":"BFnrendo2017104_CR92","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","volume":"104","author":"RA Wermers","year":"1998","unstructured":"Wermers, R. A.  et al. Survival after the diagnosis of hyperparathyroidism: a population-based study. Am. J. Med. 104, 115\u2013122 (1998).","journal-title":"Am. J. Med."},{"key":"BFnrendo2017104_CR93","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00268-002-6541-z","volume":"27","author":"P Vestergaard","year":"2003","unstructured":"Vestergaard, P.  et al. Cardiovascular events before and after surgery for primary hyperparathyroidism. World J. Surg. 27, 216\u2013222 (2003).","journal-title":"World J. Surg."},{"key":"BFnrendo2017104_CR94","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4158\/EP.14.2.155","volume":"14","author":"EA Streeten","year":"2008","unstructured":"Streeten, E. A.  et al. Coronary artery calcification in patients with primary hyperparathyroidism in comparison with control subjects from the multi-ethnic study of atherosclerosis. Endocr. Pract. 14, 155\u2013161 (2008).","journal-title":"Endocr. Pract."},{"key":"BFnrendo2017104_CR95","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10554-008-9369-2","volume":"25","author":"A Kepez","year":"2009","unstructured":"Kepez, A.  et al. Evaluation of subclinical coronary atherosclerosis in mild asymptomatic primary hyperparathyroidism patients. Int. J. Cardiovasc. Imag. 25, 187\u2013193 (2009).","journal-title":"Int. J. Cardiovasc. Imag."},{"key":"BFnrendo2017104_CR96","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0002-9343(93)90260-V","volume":"95","author":"T Stefenelli","year":"1993","unstructured":"Stefenelli, T.  et al. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am. J. Med. 95, 197\u2013202 (1993).","journal-title":"Am. J. Med."},{"key":"BFnrendo2017104_CR97","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1210\/jc.2011-2107","volume":"97","author":"S Iwata","year":"2012","unstructured":"Iwata, S.  et al. Aortic valve calcification in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 97, 132\u2013137 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR98","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1530\/EJE-12-0124","volume":"167","author":"MD Walker","year":"2012","unstructured":"Walker, M. D.  et al. Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism. Eur. J. Endocrinol. 167, 277\u2013285 (2012).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2017104_CR99","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1210\/jc.2015-3202","volume":"100","author":"DJ McMahon","year":"2015","unstructured":"McMahon, D. J.  et al. Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism: a meta-analysis. J. Clin. Endocrinol. Metab. 100, 4399\u20134407 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR100","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1067\/msy.2099.101422","volume":"126","author":"IL Nilsson","year":"1999","unstructured":"Nilsson, I. L., Aberg, J., Rastad, J. & Lind, L. Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 126, 1049\u20131055 (1999).","journal-title":"Surgery"},{"key":"BFnrendo2017104_CR101","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0895-7061(00)00248-X","volume":"13","author":"M Kosch","year":"2000","unstructured":"Kosch, M.  et al. Studies on flow-mediated vasodilation and intima\u2013media thickness of the brachial artery in patients with primary hyperparathyroidism. Am. J. Hypertens. 13, 759\u2013764 (2000).","journal-title":"Am. J. Hypertens."},{"key":"BFnrendo2017104_CR102","first-page":"887","volume":"20","author":"F Lumachi","year":"2006","unstructured":"Lumachi, F.  et al. Intima-media thickness measurement of the carotid artery in patients with primary hyperparathyroidism. A prospective case\u2013control study and long-term follow-up. In Vivo 20, 887\u2013890 (2006).","journal-title":"In Vivo"},{"key":"BFnrendo2017104_CR103","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1210\/jc.2002-021837","volume":"88","author":"F Fallo","year":"2003","unstructured":"Fallo, F.  et al. Ultrasound evaluation of carotid artery in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 88, 2096\u20132099 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR104","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/hr.2010.232","volume":"34","author":"J Rosa","year":"2011","unstructured":"Rosa, J.  et al. Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy. Hypertens. Res. 34, 296\u2013300 (2011).","journal-title":"Hypertens. Res."},{"key":"BFnrendo2017104_CR105","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.atherosclerosis.2011.05.010","volume":"218","author":"G Schillaci","year":"2011","unstructured":"Schillaci, G.  et al. Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis 218, 96\u2013101 (2011).","journal-title":"Atherosclerosis"},{"key":"BFnrendo2017104_CR106","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1210\/jc.2004-1400","volume":"90","author":"MR Rubin","year":"2005","unstructured":"Rubin, M. R., Maurer, M. S., McMahon, D. J., Bilezikian, J. P. & Silverberg, S. J. Arterial stiffness in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 90, 3326\u20133330 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR107","first-page":"884","volume":"16","author":"A Ragno","year":"2012","unstructured":"Ragno, A.  et al. Chronic constipation in hypercalcemic patients with primary hyperparathyroidism. Eur. Rev. Med. Pharmacol. Sci. 16, 884\u2013889 (2012).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"BFnrendo2017104_CR108","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s00774-013-0453-x","volume":"31","author":"J Pepe","year":"2013","unstructured":"Pepe, J.  et al. The effect of parathyroidectomy on chronic constipation in patients affected by primary hyperparathyroidism. J. Bone Miner. Metab. 31, 690\u2013694 (2013).","journal-title":"J. Bone Miner. Metab."},{"key":"BFnrendo2017104_CR109","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1210\/jc.2011-2639","volume":"97","author":"JF Ludvigsson","year":"2012","unstructured":"Ludvigsson, J. F.  et al. Primary hyperparathyroidism and celiac disease: a population-based cohort study. J. Clin. Endocrinol. Metab. 97, 897\u2013904 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR110","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1210\/jc.2008-1763","volume":"94","author":"JP Bilezikian","year":"2009","unstructured":"Bilezikian, J. P., Khan, A. A. & Potts, J. T. Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J. Clin. Endocrinol. Metab. 94, 335\u2013339 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR111","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1210\/jc.2013-1300","volume":"98","author":"NE Cusano","year":"2013","unstructured":"Cusano, N. E.  et al. Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J. Clin. Endocrinol. Metab. 98, 2734\u20132741 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR112","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1210\/jc.2002-021404","volume":"88","author":"G Maruani","year":"2003","unstructured":"Maruani, G., Hertig, A., Paillard, M. & Houillier, P. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J. Clin. Endocrinol. Metab. 88, 4641\u20134648 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR113","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1210\/jc.2012-2499","volume":"98","author":"L Rejnmark","year":"2013","unstructured":"Rejnmark, L., Amstrup, A. K., Mollerup, C. L., Heickendorff, L. & Mosekilde, L. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case\u2013control study. J. Clin. Endocrinol. Metab. 98, 87\u201396 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR114","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00774-015-0673-3","volume":"34","author":"MM Tuna","year":"2016","unstructured":"Tuna, M. M.  et al. Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism. J. Bone Miner. Metab. 34, 331\u2013335 (2016).","journal-title":"J. Bone Miner. Metab."},{"key":"BFnrendo2017104_CR115","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1210\/jc.2013-1518","volume":"98","author":"E Koumakis","year":"2013","unstructured":"Koumakis, E.  et al. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 98, 3213\u20133220 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR116","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/SLA.0000000000000812","volume":"261","author":"AG Abdulla","year":"2015","unstructured":"Abdulla, A. G., Ituarte, P. H., Harari, A., Wu, J. X. & Yeh, M. W. Trends in the frequency and quality of parathyroid surgery: analysis of 17,082 cases over 10 years. Ann. Surg. 261, 746\u2013750 (2015).","journal-title":"Ann. Surg."},{"key":"BFnrendo2017104_CR117","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.surg.2007.09.003","volume":"142","author":"AI Stavrakis","year":"2007","unstructured":"Stavrakis, A. I., Ituarte, P. H., Ko, C. Y. & Yeh, M. W. Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery. Surgery 142, 887\u2013899 (2007).","journal-title":"Surgery"},{"key":"BFnrendo2017104_CR118","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1097\/MNM.0000000000000595","volume":"37","author":"WP Kluijfhout","year":"2016","unstructured":"Kluijfhout, W. P.  et al. Fluorine-18 fluorocholine PET\u2013CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands. Nucl. Med. Commun. 37, 1246\u20131252 (2016).","journal-title":"Nucl. Med. Commun."},{"key":"BFnrendo2017104_CR119","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/01.sla.0000234899.93328.30","volume":"244","author":"R Udelsman","year":"2006","unstructured":"Udelsman, R. & Donovan, P. I. Remedial parathyroid surgery: changing trends in 130 consecutive cases. Ann. Surg. 244, 471\u2013479 (2006).","journal-title":"Ann. Surg."},{"key":"BFnrendo2017104_CR120","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1210\/jc.2004-0028","volume":"89","author":"DS Rao","year":"2004","unstructured":"Rao, D. S., Phillips, E. R., Divine, G. W. & Talpos, G. B. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 89, 5415\u20135422 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR121","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00423-012-1026-5","volume":"398","author":"L Rolighed","year":"2013","unstructured":"Rolighed, L.  et al. BMD improvements after operation for primary hyperparathyroidism. Langenbecks Arch. Surg. 398, 113\u2013120 (2013).","journal-title":"Langenbecks Arch. Surg."},{"key":"BFnrendo2017104_CR122","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/bmj.325.7368.807","volume":"325","author":"CL Mollerup","year":"2002","unstructured":"Mollerup, C. L.  et al. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ 325, 807 (2002).","journal-title":"BMJ"},{"key":"BFnrendo2017104_CR123","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1210\/jc.2007-1215","volume":"93","author":"MR Rubin","year":"2008","unstructured":"Rubin, M. R.  et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J. Clin. Endocrinol. Metab. 93, 3462\u20133470 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR124","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.surg.2016.06.062","volume":"161","author":"KA Zanocco","year":"2017","unstructured":"Zanocco, K. A., Wu, J. X. & Yeh, M. W. Parathyroidectomy for asymptomatic primary hyperparathyroidism: A revised cost-effectiveness analysis incorporating fracture risk reduction. Surgery 161, 16\u201324 (2017).","journal-title":"Surgery"},{"key":"BFnrendo2017104_CR125","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0002-9343(97)00053-3","volume":"102","author":"FG Locker","year":"1997","unstructured":"Locker, F. G., Silverberg, S. J. & Bilezikian, J. P. Optimal dietary calcium intake in primary hyperparathyroidism. Am. J. Med. 102, 543\u2013550 (1997).","journal-title":"Am. J. Med."},{"key":"BFnrendo2017104_CR126","doi-asserted-by":"publisher","first-page":"e6390","DOI":"10.1136\/bmj.e6390","volume":"345","author":"JM Paik","year":"2012","unstructured":"Paik, J. M., Curhan, G. C. & Taylor, E. N. Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study. BMJ 345, e6390 (2012).","journal-title":"BMJ"},{"key":"BFnrendo2017104_CR127","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1210\/jc.2014-1417","volume":"99","author":"C Marcocci","year":"2014","unstructured":"Marcocci, C., Bollerslev, J., Khan, A. A. & Shoback, D. M. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J. Clin. Endocrinol. Metab. 99, 3607\u20133618 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR128","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s00394-002-0383-1","volume":"41","author":"R Jorde","year":"2002","unstructured":"Jorde, R., Szumlas, K., Haug, E. & Sundsfjord, J. The effects of calcium supplementation to patients with primary hyperparathyroidism and a low calcium intake. Eur. J. Nutr. 41, 258\u2013263 (2002).","journal-title":"Eur. J. Nutr."},{"key":"BFnrendo2017104_CR129","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1210\/jc.2016-2481","volume":"102","author":"G Tsvetov","year":"2017","unstructured":"Tsvetov, G.  et al. Thiazide treatment in primary hyperparathyroidism \u2014 a new indication for an old medication? J. Clin. Endocrinol. Metab. 102, 1270\u20131276 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2017104_CR130","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/cen.13046","volume":"85","author":"P Riss","year":"2016","unstructured":"Riss, P.  et al. The influence of thiazide intake on calcium and parathyroid hormone levels in patients with primary hyperparathyroidism. Clin. Endocrinol. (Oxf.) 85, 196\u2013201 (2016).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2017104_CR131","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/pgmj.66.779.714","volume":"66","author":"CW Farquhar","year":"1990","unstructured":"Farquhar, C. W., Spathis, G. S., Barron, J. L. & Levin, G. E. Failure of thiazide diuretics to increase plasma calcium in mild primary hyperparathyroidism. Postgrad. Med. J. 66, 714\u2013716 (1990).","journal-title":"Postgrad. Med. J."},{"key":"BFnrendo2017104_CR132","doi-asserted-by":"publisher","first-page":"360","DOI":"10.7326\/0003-4819-125-5-199609010-00002","volume":"125","author":"AB Grey","year":"1996","unstructured":"Grey, A. B., Stapleton, J. P., Evans, M. C., Tatnell, M. A. & Reid, I. R. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial. Ann. Intern. Med. 125, 360\u2013368 (1996).","journal-title":"Ann. Intern. Med."},{"key":"BFnrendo2017104_CR133","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00774-013-0473-6","volume":"32","author":"S Tournis","year":"2014","unstructured":"Tournis, S.  et al. Effect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism. J. Bone Miner. Metab. 32, 151\u2013158 (2014).","journal-title":"J. Bone Miner. Metab."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2017.104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2017.104","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrendo.2017.104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2017.104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T02:07:19Z","timestamp":1650074839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2017.104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,8]]},"references-count":133,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["BFnrendo2017104"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2017.104","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,8]]},"assertion":[{"value":"8 September 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}